Literature DB >> 34732607

Multiplex PCR method for differentiating highly pathogenic Yersinia enterocolitica and low pathogenic Yersinia enterocolitica, and Yersinia pseudotuberculosis.

Thi Hien Bui1, Shunsuke Ikeuchi1, Yukiko Sassa O'Brien1, Takeshi Niwa1, Yukiko Hara-Kudo2, Takahide Taniguchi1, Hideki Hayashidani1.   

Abstract

A multiplex PCR method for rapid and sensitive diagnosis, differentiating three pathogenic Yersinia groups such as the highly pathogenic Y. enterocolitica, including serotype O8, low pathogenic Y. enterocolitica, and Y. pseudotuberculosis, was developed. Four primer pairs were chosen to detect the genes fyuA, ail, inv, and virF, responsible for the virulence in pathogenic Yersinia species. Under the multiplex PCR conditions, the unique band patterns for the highly pathogenic Y. enterocolitica, low pathogenic Y. enterocolitica, and Y. pseudotuberculosis were generated from Yersinia strains. The detection limit of this method was 101-103 CFU per reaction tube. This multiplex PCR method could detect highly pathogenic Y. enterocolitica O8 from the wild rodent fecal samples that were culture-positive. Therefore, the new multiplex PCR method developed in this study is a useful tool for rapid and sensitive diagnosis, distinguishing three pathogenic Yersinia groups.

Entities:  

Keywords:  Yersinia enterocolitica; Yersinia pseudotuberculosis; detection; diagnosis; multiplex PCR

Mesh:

Year:  2021        PMID: 34732607      PMCID: PMC8762423          DOI: 10.1292/jvms.21-0358

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


Pathogenic bacteria of the Yersinia genus, including Yersinia enterocolitica and Yersinia pseudotuberculosis, are known to cause yersiniosis [2, 4, 5]. From over 60 Y. enterocolitica serotypes, only nine serotypes (O3, O4,32, O5,27, O8, O9, O13, O18, O20, and O21) are pathogenic to humans [2, 5]. Among them, serotypes O3, O5,27, and O9 are called “European strains”, and show low pathogenicity to humans. In contrast, the remaining six serotypes, which are called “American strains”, are highly pathogenic to humans [3, 4]. Generally, human Yersinia infection causes gastroenteritis with clinical symptoms including abdominal pain, diarrhea, and fever, however, highly pathogenic Y. enterocolitica serotypes including serotype O8 and Y. pseudotuberculosis sometimes cause septicemia [2, 4, 5]. In the highly pathogenic Y. enterocolitica serotypes, recently serotype O8 has been increasing in Japan [9, 15, 23] and in some European countries such as Germany and Poland [18, 19]. Therefore, a sensitive and rapid method for detecting these pathogens is required. The diagnostic methods for pathogenic Yersinia are mainly based on conventional isolation and identification procedures [7, 13]; however, these methods are time-consuming and laborious. Recently, some PCR methods have been developed to detect Y. enterocolitica and Y. pseudotuberculosis, allowing rapid diagnosis [6, 20]. A few multiplex PCR methods have been developed to detect both pathogenic Y. enterocolitica and Y. pseudotuberculosis [16, 21]. However, the multiplex PCR method to detect highly pathogenic Y. enterocolitica, including serotype O8, low pathogenic Y. enterocolitica, and Y. pseudotuberculosis, has not been established. Therefore, the study aimed to develop a rapid multiplex PCR method for the detection and identification of highly pathogenic Y. enterocolitica, low pathogenic Y. enterocolitica, and Y. pseudotuberculosis, and evaluate the performance of the method in the detection of highly pathogenic Y. enterocolitica O8 from clinical samples.

MATERIALS AND METHODS

Bacterial strains

A total of 25 strains of pathogenic Yersinia, including 6 strains of low pathogenic Y. enterocolitica serotypes, 9 strains of highly pathogenic serotypes, and 10 strains of pathogenic Y. pseudotuberculosis were used in this study. Moreover, non-pathogenic Y. enterocolitica serotype O8,19, Y. aldovae, Y. intermedia, Y. kristensenii, Y. rohdei, Escherichia coli, and Salmonella enterica subsp. enterica serovar Enteritidis were used to verify the specificity of the multiplex PCR method (Table 1). These strains were stored in skim milk at −80°C until analysis.
Table 1.

Bacteria strains and band patterns of each bacteria by the polymerase chain reaction (PCR) method

SpeciesBiotypeSerotypeStrainPCR results

invfyuAailvirF
Yersinia enterocolitica4O3S3-3--++
Y. enterocolitica4O3S3-8--++
Y. enterocolitica1BO4,32IP96-+++
Y. enterocolitica2O5,27S5-250--++
Y. enterocolitica2O5,27S5-203--++
Y. enterocolitica1BO8Ye16-58-+++
Y. enterocolitica1BO8NY9306089-+++
Y. enterocolitica1BO8IP843-+++
Y. enterocolitica2O9S9-87--++
Y. enterocolitica2O9Pa117--++
Y. enterocolitica1BO13a,13bWA285-+++
Y. enterocolitica1BO13a,13bWAT568-+++
Y. enterocolitica1BO18,13bIP896-+++
Y. enterocolitica1BO20IP1106-+++
Y. enterocolitica1BO21IP1110-+++
Y. pseudotuberculosis1bSP-20+--+
Y. pseudotuberculosis1bSP-1526+--+
Y. pseudotuberculosis2b1608+--+
Y. pseudotuberculosis3SP-148+--+
Y. pseudotuberculosis3SP-1726+--+
Y. pseudotuberculosis4bSP-2067+--+
Y. pseudotuberculosis4bSP-2118+--+
Y. pseudotuberculosis5aSP-328+--+
Y. pseudotuberculosis5aSP-334+--+
Y. pseudotuberculosis6SP-901+--+
Y. enterocolitica1AO8,19NY8904001----
Y. aldovaeJCM 5892----
Y. intermediaJCM 7579----
Y. kristenseniiJCM 7576----
Y. rohdeiJCM 7376----
Salmonella enterica subsp. enterica serovar EnteritidisNS9506003----
Escherichia coliJCM 5491----

DNA extraction for multiplex PCR

All bacterial strains were plated on trypticase soy agar (TSA, Becton, Dickinson and Co., Franklin Lakes, NJ, USA) and incubated for 24 hr at 25°C. After suspending the bacterial cells of each strain in TE buffer (10 mM Tris-HCl [pH 8.0], 1 mM EDTA), genomic DNA was extracted using the alkali-heat DNA extraction method described previously [8]. Briefly, 200 μl of the bacterial suspension was centrifuged at 10,000 × g for 10 min. The collected pellet was resuspended in 85 μl of sterilized 50 mM NaOH, followed by heating at 100°C for 10 min. After cooling on ice, the suspension was neutralized with 15 μl of sterilized 1 M Tris-HCl (pH 7.0) and centrifuged at 10,000 × g for 10 min. The supernatant containing the DNA template was collected and used for the multiplex PCR.

Primer selection

The target genes were selected based on their ability to identify all pathogenic Yersinia, including highly pathogenic Y. enterocolitica, low pathogenic Y. enterocolitica, and Y. pseudotuberculosis. These genes included fyuA (ferric yersiniabactin uptake receptor A), present on chromosomal DNA of highly pathogenic Y. enterocolitica [17]; ail (attachment invasion locus), found uniquely on the chromosome of pathogenic Y. enterocolitica strains [14, 20]; inv (invasin), present on the chromosome of pathogenic Y. pseudotuberculosis [20]; and virF (virulence regulon transcriptional activator), which is encoded on a 70 kilobase plasmid (pYV) of pathogenic Y. enterocolitica and Y. pseudotuberculosis [4]. PCR primers targeting the fyuA gene were designed for this study. A region of the fyuA gene sequence of Y. enterocolitica serotype O8 (GenBank accession no. Z35486.1), which lacks homology with the fyuA gene sequence of Y. pseudotuberculosis was chosen to design fyuA gene-specific primers using the Primer-BLAST software [22]. The primer pairs for inv, ail, and virF were designed by Thoerner et al. [20]. The details of primers to each target genes are shown in Table 2.
Table 2.

Oligonucleotide primers used in this study

Target genesSequences (5′-3′)Product length (bp)Target pathogensReferences
invFCGGTACGGCTCAAGTTAATCTG183Pathogenic Yersinia pseudotuberculosis [20]
RCCGTTCTCCAATGTACGTATCC
fyuAFGGCCGTAAGCTCTCACTT253Highly pathogenic Y. enterocolitica (American strains)This study
RACACCATATCAACGGTACGC
ailFTAATGTGTACGCTGCGAG351Pathogenic Y. enterocolitica [20]
RGACGTCTTACTTGCACTG
virFFGGCAGAACAGCAGTCAGACATA561Pathogenic Y. enterocolitica and Y. pseudotuberculosis [20]
RGGTGAGCATAGAGAATACGTCG

F, forward primer; R, reverse primer.

F, forward primer; R, reverse primer.

Multiplex PCR method

Initially, monoplex PCR using each primer pair was performed to observe the distribution of target genes among pathogenic Yersinia species. After validation of each pair, these four primer pairs were combined to confirm that each PCR product was the correct size. Subsequently, the multiplex PCR conditions were optimized. Each reaction mixture (15 μl) contained 0.1 μM of each primer, 1X Green buffer of Gotaq Flexi DNA polymerase kit (Promega Corp., Madison, WI, USA), 2.5 mM MgCl2, 200 μM dNTP, 0.05 U Gotaq DNA polymerase (Promega), and 5 μl of template DNA. The reaction was performed in a T100 Thermal Cycler (Bio-Rad Laboratories, Inc., Hercules, CA, USA) under the following conditions: initial denaturation step for 2 min at 95°C, followed by 30 cycles of 95°C for 30 sec, 56°C for 30 sec, 72°C for 30 sec, and a final extension at 72°C for 5 min. The PCR products were then subjected to electrophoresis on 1.5% agarose ME (Fujifilm Wako Pure Chemical Corp., Osaka, Japan) gel in 1X Tris-acetic acid EDTA buffer (Fujifilm Wako Pure Chemical Corp.) at 100 V for 30 min and stained with AtlasSight DNA Stain (Bioatlas, Tartu, Estonia).

Sensitivity test of developed multiplex PCR

The sensitivity of the developed multiplex PCR was examined using Y. enterocolitica O3 (strain S3-3), Y. enterocolitica O8 (strain YE16-58), Y. pseudotuberculosis 1b (strain SP-20), and Y. pseudotuberculosis 4b (strain SP-2067). The bacterial cells of each strain from colonies on TSA were suspended in TE buffer to achieve a final concentration of 109 CFU/ml. To examine the detection limits for the developed multiplex PCR, a serial 10-fold dilution of these strains with TE buffer was performed. Genomic DNA from each dilution was obtained using the alkaline-heat DNA extraction method described above and was used for multiplex PCR amplification. Aliquots of the serial dilutions were plated in duplicates onto TSA and grown at 25°C for 24 hr to determine the number of colony-forming units (CFU).

Detection of pathogenic Yersinia from fecal samples

To evaluate the performance of the multiplex PCR developed in this study to detect pathogenic Yersinia in clinical samples, a total of 45 wild rodent feces contaminated with Y. enterocolitica O8 were used. The fecal samples (0.5 g) were suspended in 4.5 ml of phosphate-buffered saline (PBS; pH 7.6), and 200 μl of the PBS suspension was subjected to DNA extraction. Genomic DNA was extracted immediately after the fecal samples were homogenized in PBS without enrichment. It was purified using the QIAamp DNA stool mini kit (Qiagen GmbH, Hilden, Germany) following the manufacturer’s instructions, with 100 μl elution buffer added for DNA collection and used for multiplex PCR amplification. Y. enterocolitica O8 was isolated from wild rodent feces using the cold enrichment culture method and was identified as described previously [10].

RESULTS

The specificity of the developed multiplex PCR

The results of the specificity test for the monoplex and multiplex PCR are shown in Table 1. Detection of the fyuA, ail, inv, and virF genes correlated well with the genotypic traits of highly pathogenic Y. enterocolitica, low pathogenic Y. enterocolitica, and Y. pseudotuberculosis. Typical examples of multiplex PCR assays for pathogenic Yersinia species are shown in Fig. 1. Among the 25 different pathogenic Yersinia strains, only highly pathogenic Y. enterocolitica showed an extra PCR product of 253 bp, which corresponded to a part of the fyuA gene. The 351 bp fragment of the ail gene was observed in all the pathogenic Y. enterocolitica serotypes, and the 183 bp fragment of the inv gene was detected in all the Y. pseudotuberculosis serotypes. The amplicon of 561 bp, which corresponded to a part of the virF gene, was observed in all the pathogenic Yersinia serotypes tested. The pattern with two bands, 253 bp, and 351 bp, indicated the presence of a highly pathogenic Y. enterocolitica strains. The single-band, 351 bp corresponded to low pathogenic Y. enterocolitica strains, and 183 bp corresponded to Y. pseudotuberculosis strains. The 561 bp band indicated the presence of a virulent plasmid of the Yersinia strains. Thus, the highly pathogenic Y. enterocolitica, pathogenic Y. enterocolitica, and Y. pseudotuberculosis can be differentiated by three different band patterns. No targeted gene products were amplified from the negative controls (Fig. 1).
Fig. 1.

Agarose gel electrophoresis results for the developed multiplex PCR method with representative isolates of pathogenic Yersinia serotypes. Lanes O3, O5, O8, and O9, Y. enterocolitica serotype O3, O5,27, O8, and O9, respectively; lanes 1b, 2b, 3, 4b, 5a, and 6, Y. pseudotuberculosis serotype 1b, 2b, 3, 4b, 5a and 6, respectively; lane Y.int., Y. intermedia; lane EC, Escherichia coli; lane SE, Salmonella enterica subsp. enterica serovar Enteritidis. Lane N, multiplex PCR in the absence of template DNA. Lane MIX, Mix DNA of Y. enterocolitica O8 and Y. pseudotuberculosis 1b. Lane M, 100 bp DNA ladder (TaKaRa Bio Inc., Kusatsu, Japan).

Agarose gel electrophoresis results for the developed multiplex PCR method with representative isolates of pathogenic Yersinia serotypes. Lanes O3, O5, O8, and O9, Y. enterocolitica serotype O3, O5,27, O8, and O9, respectively; lanes 1b, 2b, 3, 4b, 5a, and 6, Y. pseudotuberculosis serotype 1b, 2b, 3, 4b, 5a and 6, respectively; lane Y.int., Y. intermedia; lane EC, Escherichia coli; lane SE, Salmonella enterica subsp. enterica serovar Enteritidis. Lane N, multiplex PCR in the absence of template DNA. Lane MIX, Mix DNA of Y. enterocolitica O8 and Y. pseudotuberculosis 1b. Lane M, 100 bp DNA ladder (TaKaRa Bio Inc., Kusatsu, Japan).

The sensitivity of the developed multiplex PCR

The results showed that multiplex PCR was able to detect pathogenic Yersinia with 101–103 CFU per reaction tube. Among the four strains tested, Y. enterocolitica O8 (strain YE16-58) and two strains of Y. pseudotuberculosis 1b (strain SP-20) and 4b (strain SP-2067) were detectable at 101 CFU per reaction tube. However, more than 103 CFU per reaction tube was required to detect Y. enterocolitica O3 (strain S3-3) (Fig. 2).
Fig. 2.

Detection limits of the multiplex PCR developed in this study. The numbers above each lane represent 106, 105, 104, 103, 102, 101, and 100 CFU per reaction tube of template DNA of Yersinia enterocolitica O3 (strain S3-3) (A); Y. enterocolitica O8 (strain YE16-58) (B); Y. pseudotuberculosis 1b (strain SP-20) (C); and Y. pseudotuberculosis 4b (strain SP-2067) (D). Lane M, 100 bp DNA ladder (TaKaRa Bio Inc., Kusatsu, Japan).

Detection limits of the multiplex PCR developed in this study. The numbers above each lane represent 106, 105, 104, 103, 102, 101, and 100 CFU per reaction tube of template DNA of Yersinia enterocolitica O3 (strain S3-3) (A); Y. enterocolitica O8 (strain YE16-58) (B); Y. pseudotuberculosis 1b (strain SP-20) (C); and Y. pseudotuberculosis 4b (strain SP-2067) (D). Lane M, 100 bp DNA ladder (TaKaRa Bio Inc., Kusatsu, Japan). The multiplex PCR results were in agreement with those from the culture method (Table 3 and Fig. 3). Among the 45 naturally contaminated wild rodent fecal samples tested, simultaneous amplification of the virF, ail, and fyuA genes was observed in three (6.7%) samples, indicating the presence of highly pathogenic Y. enterocolitica O8. These samples were the same as those of the culture-positive samples. No PCR product was observed in the culture-negative samples.
Table 3.

Comparison of multiplex PCR method with culture method in detecting pathogenic Yersinia from wild rodent fecal samples

MethodsNo. of samplesY. enterocoliticaY. pseudotuberculosis
Multiplex PCR453 (6.7%)§0
Culture3 (6.7%)§0

Yersinia enterocolitica O8.

Fig. 3.

Band pattern of the developed multiplex PCR for Yersinia from fecal samples and Yersinia isolates from wild rodents. Lane M, 100 bp DNA ladder (TaKaRa Bio Inc., Kusatsu, Japan). Lanes 7F, 23F, 44F, mice fecal samples number 7, 23, and 44, respectively; 7B, 23B, 44B, Yersinia isolates from mice fecal samples number 7, 23, and 44, respectively. Lane O8, positive control Y. enterocolitica O8. Lane N, multiplex PCR in the absence of template DNA.

Yersinia enterocolitica O8. Band pattern of the developed multiplex PCR for Yersinia from fecal samples and Yersinia isolates from wild rodents. Lane M, 100 bp DNA ladder (TaKaRa Bio Inc., Kusatsu, Japan). Lanes 7F, 23F, 44F, mice fecal samples number 7, 23, and 44, respectively; 7B, 23B, 44B, Yersinia isolates from mice fecal samples number 7, 23, and 44, respectively. Lane O8, positive control Y. enterocolitica O8. Lane N, multiplex PCR in the absence of template DNA.

DISCUSSION

A few multiplex PCR methods to detect Y. enterocolitica and Y. pseudotuberculosis have been reported [16, 21]. However, no reports are available on the multiplex PCR method for simultaneous detection and identification of low and high pathogenic Y. enterocolitica at the same time. A rapid, specific, and sensitive multiplex PCR method, which can detect and distinguish the three pathogenic Yersinia groups consisting of highly pathogenic Y. enterocolitica, including serotype O8, low pathogenic Y. enterocolitica, and Y. pseudotuberculosis, was developed in this study. A new primer pair targeting fyuA was designed to detect highly pathogenic Y. enterocolitica. This fyuA primer pair was combined with the ail, inv, and virF primer pairs described previously by Thoerner et al. [20] to allow both detection and differentiation among the three pathogenic Yersinia groups. The primer pairs, ail, inv, and virF, were initially designed and used in conventional monoplex PCR assays [20]. Under the multiplex PCR conditions, with a mixture of these four pairs of primers (Fig. 1), three groups of pathogenic Yersinia, were distinguished. Moreover, the detection limit of the multiplex PCR method was 101–103 CFU per reaction tube, which demonstrated a high sensitivity level [11, 16]. A spike experiment using Yersinia-free pig fecal samples was performed, and the multiplex PCR method developed in this study could detect pathogenic Yersinia at 101–103 CFU per reaction tube from spiked fecal samples (data not shown). However, few reports [1, 12] have stated that some primer sets of PCR methods for detecting pathogenic Yersinia showed high sensitivity in spiked fecal samples but not in naturally contaminated samples. Therefore, the multiplex PCR method was applied to detect pathogenic Yersinia from wild rodent feces contaminated with Y. enterocolitica O8 to determine the feasibility of this method as a diagnostic tool. The multiplex PCR method developed in this study could detect Y. enterocolitica O8 from the same rodent fecal samples that were culture-positive (Table 3, Fig. 3). While the conventional culture method is time-consuming and laborious [7, 13], the multiplex PCR method can be completed within one day. Therefore, the multiplex PCR developed in this study seems to be a useful method for rapid and sensitive diagnosis, distinguishing three pathogenic Yersinia groups such as highly pathogenic Y. enterocolitica, including Y. enterocolitica O8, low pathogenic Y. enterocolitica, and Y. pseudotuberculosis.

CONFLICT OF INTEREST STATEMENT

The authors declare no conflicts of interest
  18 in total

1.  Four Sporadic Pediatric Cases of Yersinia enterocolitica O:8 Infection in a Rural Area of Japan.

Authors:  Kisei Minami; Ryu Yasuda; Runa Terakawa; Yumi Koike; Koichi Takeuchi; Tsukasa Higuchi; Ayaka Horiuchi; Noriko Kubota; Eiko Hidaka; Yoshiyuki Kawakami
Journal:  Jpn J Infect Dis       Date:  2016-05-09       Impact factor: 1.362

2.  An interlaboratory study on efficient detection of Shiga toxin-producing Escherichia coli O26, O103, O111, O121, O145, and O157 in food using real-time PCR assay and chromogenic agar.

Authors:  Yukiko Hara-Kudo; Noriko Konishi; Kayoko Ohtsuka; Kaori Iwabuchi; Rie Kikuchi; Junko Isobe; Takumiko Yamazaki; Fumie Suzuki; Yuhki Nagai; Hiroko Yamada; Atsuko Tanouchi; Tetsuya Mori; Hiroshi Nakagawa; Yasufumi Ueda; Jun Terajima
Journal:  Int J Food Microbiol       Date:  2016-04-13       Impact factor: 5.277

3.  PCR detection of virulence genes in Yersinia enterocolitica and Yersinia pseudotuberculosis and investigation of virulence gene distribution.

Authors:  P Thoerner; C I Bin Kingombe; K Bögli-Stuber; B Bissig-Choisat; T M Wassenaar; J Frey; T Jemmi
Journal:  Appl Environ Microbiol       Date:  2003-03       Impact factor: 4.792

4.  Epidemiology of reported Yersinia enterocolitica infections in Germany, 2001-2008.

Authors:  Bettina M Rosner; Klaus Stark; Dirk Werber
Journal:  BMC Public Health       Date:  2010-06-14       Impact factor: 3.295

5.  Comparison of multiplex PCR, PCR-ELISA and fluorogenic 5' nuclease PCR assays for detection of plasmid-bearing virulent Yersinia enterocolitica in swine feces.

Authors:  S Bhaduri
Journal:  Mol Cell Probes       Date:  2002-06       Impact factor: 2.365

6.  Detection and identification of Yersinia pseudotuberculosis and pathogenic Yersinia enterocolitica by an improved polymerase chain reaction method.

Authors:  H Nakajima; M Inoue; T Mori; K Itoh; E Arakawa; H Watanabe
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

Review 7.  Low occurrence of pathogenic Yersinia enterocolitica in clinical, food, and environmental samples: a methodological problem.

Authors:  Maria Fredriksson-Ahomaa; Hannu Korkeala
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

8.  Potential sources of sporadic human infection with Yersinia enterocolitica serovar O:8 in Aomori Prefecture, Japan.

Authors:  H Hayashidani; Y Ohtomo; Y Toyokawa; M Saito; K Kaneko; J Kosuge; M Kato; M Ogawa; G Kapperud
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

9.  [Two Outbreaks of Yersinia enterocolitica O:8 Infections in Tokyo and the Characterization of Isolates].

Authors:  Noriko Konishi; Rie Ishitsuka; Keiko Yokoyama; Dai Saiki; Satoru Akase; Chie Monma; Akihiko Hirai; Kenji Sadamasu; Akemi Kai
Journal:  Kansenshogaku Zasshi       Date:  2016-01

10.  Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction.

Authors:  Jian Ye; George Coulouris; Irena Zaretskaya; Ioana Cutcutache; Steve Rozen; Thomas L Madden
Journal:  BMC Bioinformatics       Date:  2012-06-18       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.